KUKA Introduces Innovative Medical Robots for the Operating Room (OR) at MEDICA 2021
|
By LabMedica International staff writers Posted on 15 Nov 2021 |

Image: LBR Med (Photo courtesy of KUKA AG)
KUKA AG (Augsburg, Germany) presented new application examples for its robots in the medical technology sector at this year's MEDICA, the world's largest annual medical technology trade fair, which took place from 15-18 November in Düsseldorf, Germany. At the 2021 edition of MEDICA, more than 5,000 exhibitors from 70 countries presented their newest products and ideas. The event also drew more than 120,000 trade visitors from over 170 countries.
KUKA is a supplier of intelligent automation solutions and offers robotic solutions for the medical and healthcare sectors. Robot systems from KUKA are suitable for a wide range of applications in robotic medical technology: from diagnosis and operations to rehabilitation. At MEDICA 2021, KUKA presented innovative ideas for robot-based applications in medicine, such as the collaborative LBR Med which is perfectly suited for various tasks in the medical field, thanks to its sensitive sensor technology. From diagnostics to treatment and surgical interventions – the LBR Med stands out as a perfect assistant for diverse tasks in the field of healthcare. The sensitive seven-axis lightweight robot is flexible and easy to integrate into medical products for various medical activities. With its responsive sensors, comprehensive safety precautions, hygiene-optimized surfaces and a controller designed for direct collaboration with the human operator, it is ideally suited to applications in medical technology.
KUKA demonstrated some of the possible applications of the LBR Med with the help of a medical feature cell, for example with an ultrasound-demo and a spine application. An ultrasound probe attached to the flange was guided over the body, and KUKA demonstrated how the robot records the path and then repeats the learned path independently and with constant pressure. It also demonstrated how the robot can take a change in the surface into account and continued to follow the path with the appropriate adjustment.
Additionally, KUKA’s long-time partner BEC presented guidoo - a robot-assisted surgical assistance system. The system is based on the LBR Med and enables safe and precise tissue removal during percutaneous interventions, i.e. the insertion of needles under the skin. This relieves doctors and minimizes collateral tissue damage.
Related Links:
KUKA AG
KUKA is a supplier of intelligent automation solutions and offers robotic solutions for the medical and healthcare sectors. Robot systems from KUKA are suitable for a wide range of applications in robotic medical technology: from diagnosis and operations to rehabilitation. At MEDICA 2021, KUKA presented innovative ideas for robot-based applications in medicine, such as the collaborative LBR Med which is perfectly suited for various tasks in the medical field, thanks to its sensitive sensor technology. From diagnostics to treatment and surgical interventions – the LBR Med stands out as a perfect assistant for diverse tasks in the field of healthcare. The sensitive seven-axis lightweight robot is flexible and easy to integrate into medical products for various medical activities. With its responsive sensors, comprehensive safety precautions, hygiene-optimized surfaces and a controller designed for direct collaboration with the human operator, it is ideally suited to applications in medical technology.
KUKA demonstrated some of the possible applications of the LBR Med with the help of a medical feature cell, for example with an ultrasound-demo and a spine application. An ultrasound probe attached to the flange was guided over the body, and KUKA demonstrated how the robot records the path and then repeats the learned path independently and with constant pressure. It also demonstrated how the robot can take a change in the surface into account and continued to follow the path with the appropriate adjustment.
Additionally, KUKA’s long-time partner BEC presented guidoo - a robot-assisted surgical assistance system. The system is based on the LBR Med and enables safe and precise tissue removal during percutaneous interventions, i.e. the insertion of needles under the skin. This relieves doctors and minimizes collateral tissue damage.
Related Links:
KUKA AG
Latest Medica 2021 News
- MEDICA 2021 + COMPAMED 2021 Far Exceed Expectations and Achieve Extremely Successful Results
- POC System that Requires Single DNA Molecule for Rapid Detection of Multidrug-Resistant Pathogens Unveiled at MEDICA 2021
- Icomes Lab Demonstrates World's Smallest and Lightest Electronic Pipette for PCR Testing at MEDICA 2021
- Bosch Exhibits Vivalytic All-in-One Analyzer for PCR Rapid Tests at MEDICA 2021
- Co-Diagnostics Introduces Its Revolutionary Coprimer Technology at MEDICA 2021
- MGI Tech Showcases World-First High-Throughput Automated Sample Transfer Processing System at MEDICA 2021
- Edan Debuts Next-Gen Blood Gas & Chemistry Analyzer and Patient Monitor at MEDICA 2021
- EKF Diagnostics Showcases STAT-Site WB β-ketone and Glucose Handheld Analyzer Live & in Person at MEDICA 2021
- Boditech Launches New Automated Immunoassay Analyzer with Blood Collection Tube at MEDICA 2021
- Molgen Presents Diagnostics Chemistry, Flows and Systems at MEDICA 2021
- Randox Showcases Extensive Range of Revolutionary Diagnostic Analyzers at MEDICA 2021
- Molbio Exhibits Its Novel POC Molecular Platform and Truenat Range of Tests at MEDICA 2021
- Greiner Bio-One Exhibits Its New Generation of Sapphire Pipette Tips at MEDICA 2021
- LumiraDx Presents Its Innovative, Next Generation Point of Care Diagnostics Platform at MEDICA 2021
- Medix Biochemica Celebrates Launch of New Molecular Diagnostic Reagents Division at MEDICA 2021
- Fujirebio Highlights Its Innovative IVD Testing Solutions for Today and Tomorrow at MEDICA 2021
Channels
Clinical Chemistry
view channel
Chemical Imaging Probe Could Track and Treat Prostate Cancer
Prostate cancer remains a leading cause of illness and death among men, with many patients eventually developing resistance to standard hormone-blocking therapies. These drugs often lose effectiveness... Read more
Mismatch Between Two Common Kidney Function Tests Indicates Serious Health Problems
Creatinine has long been the standard for measuring kidney filtration, while cystatin C — a protein produced by all human cells — has been recommended as a complementary marker because it is influenced... Read moreMolecular Diagnostics
view channel
Simple Urine Test to Revolutionize Bladder Cancer Diagnosis and Treatment
Bladder cancer is one of the most common and deadly urological cancers and is marked by a high rate of recurrence. Diagnosis and follow-up still rely heavily on invasive cystoscopy or urine cytology, which... Read more
Blood Test to Enable Earlier and Simpler Detection of Liver Fibrosis
Persistent liver damage caused by alcohol misuse or viral infections can trigger liver fibrosis, a condition in which healthy tissue is gradually replaced by collagen fibers. Even after successful treatment... Read moreHematology
view channel
Platelet Activity Blood Test in Middle Age Could Identify Early Alzheimer’s Risk
Early detection of Alzheimer’s disease remains one of the biggest unmet needs in neurology, particularly because the biological changes underlying the disorder begin decades before memory symptoms appear.... Read more
Microvesicles Measurement Could Detect Vascular Injury in Sickle Cell Disease Patients
Assessing disease severity in sickle cell disease (SCD) remains challenging, especially when trying to predict hemolysis, vascular injury, and risk of complications such as vaso-occlusive crises.... Read more
ADLM’s New Coagulation Testing Guidance to Improve Care for Patients on Blood Thinners
Direct oral anticoagulants (DOACs) are one of the most common types of blood thinners. Patients take them to prevent a host of complications that could arise from blood clotting, including stroke, deep... Read moreImmunology
view channel
New Test Distinguishes Vaccine-Induced False Positives from Active HIV Infection
Since HIV was identified in 1983, more than 91 million people have contracted the virus, and over 44 million have died from related causes. Today, nearly 40 million individuals worldwide live with HIV-1,... Read more
Gene Signature Test Predicts Response to Key Breast Cancer Treatment
DK4/6 inhibitors paired with hormone therapy have become a cornerstone treatment for advanced HR+/HER2– breast cancer, slowing tumor growth by blocking key proteins that drive cell division.... Read more
Chip Captures Cancer Cells from Blood to Help Select Right Breast Cancer Treatment
Ductal carcinoma in situ (DCIS) accounts for about a quarter of all breast cancer cases and generally carries a good prognosis. This non-invasive form of the disease may or may not become life-threatening.... Read moreMicrobiology
view channel
Rapid Diagnostic Test Matches Gold Standard for Sepsis Detection
Sepsis kills 11 million people worldwide every year and generates massive healthcare costs. In the USA and Europe alone, sepsis accounts for USD 100 billion in annual hospitalization expenses.... Read moreRapid POC Tuberculosis Test Provides Results Within 15 Minutes
Tuberculosis remains one of the world’s deadliest infectious diseases, and reducing new cases depends on identifying individuals with latent infection before it progresses. Current diagnostic tools often... Read more
Rapid Assay Identifies Bloodstream Infection Pathogens Directly from Patient Samples
Bloodstream infections in sepsis progress quickly and demand rapid, precise diagnosis. Current blood-culture methods often take one to five days to identify the pathogen, leaving clinicians to treat blindly... Read morePathology
view channel
Tunable Cell-Sorting Device Holds Potential for Multiple Biomedical Applications
Isolating rare cancer cells from blood is essential for diagnosing metastasis and guiding treatment decisions, but remains technically challenging. Many existing techniques struggle to balance accuracy,... Read moreAI Tool Outperforms Doctors in Spotting Blood Cell Abnormalities
Diagnosing blood disorders depends on recognizing subtle abnormalities in cell size, shape, and structure, yet this process is slow, subjective, and requires years of expert training. Even specialists... Read moreTechnology
view channel
Artificial Intelligence Model Could Accelerate Rare Disease Diagnosis
Identifying which genetic variants actually cause disease remains one of the biggest challenges in genomic medicine. Each person carries tens of thousands of DNA changes, yet only a few meaningfully alter... Read more
AI Saliva Sensor Enables Early Detection of Head and Neck Cancer
Early detection of head and neck cancer remains difficult because the disease produces few or no symptoms in its earliest stages, and lesions often lie deep within the head or neck, where biopsy or endoscopy... Read moreIndustry
view channel
Abbott Acquires Cancer-Screening Company Exact Sciences
Abbott (Abbott Park, IL, USA) has entered into a definitive agreement to acquire Exact Sciences (Madison, WI, USA), enabling it to enter and lead in fast-growing cancer diagnostics segments.... Read more









